{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:12Z","timestamp":1793411112841,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,12]]},"DOI":"10.1093\/neuonc\/noy067","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T15:58:55Z","timestamp":1524671935000},"page":"1643-1651","source":"Crossref","is-referenced-by-count":106,"title":["Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1"],"prefix":"10.1093","volume":"20","author":[{"given":"Andrea M","family":"Gross","sequence":"first","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurbani","family":"Singh","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivandana","family":"Akshintala","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Baldwin","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Dombi","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somto","family":"Ukwuani","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Goodwin","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Liewehr","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute (NCI) of the National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth M","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute (NCI) of the National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte C","family":"Widemann","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,28]]},"reference":[{"issue":"4","key":"key\n\t\t\t\t2018111205554742400_CIT0001","first-page":"443","article-title":"Optimizing biologically targeted clinical trials for neurofibromatosis","volume":"22","author":"Gutmann","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t2018111205554742400_CIT0002","first-page":"53","article-title":"Dissecting clinical heterogeneity in neurofibromatosis type 1","volume":"12","author":"Monroe","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"14","key":"key\n\t\t\t\t2018111205554742400_CIT0003","first-page":"1590","article-title":"How does the Schwann cell lineage form tumors in NF1","volume":"56","author":"Carroll","year":"2008","journal-title":"Glia"},{"issue":"1","key":"key\n\t\t\t\t2018111205554742400_CIT0004","first-page":"31","article-title":"Plexiform neurofibromas","volume":"89","author":"Korf","year":"1999","journal-title":"Am J Med Genet"},{"issue":"4","key":"key\n\t\t\t\t2018111205554742400_CIT0005","first-page":"593","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t2018111205554742400_CIT0006","first-page":"461","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J Pediatr"},{"issue":"4","key":"key\n\t\t\t\t2018111205554742400_CIT0007","first-page":"652","article-title":"Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits","volume":"159","author":"Nguyen","year":"2011","journal-title":"J Pediatr"},{"issue":"16","key":"key\n\t\t\t\t2018111205554742400_CIT0008","first-page":"1273","article-title":"Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas","volume":"73","author":"Kim","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"key\n\t\t\t\t2018111205554742400_CIT0009","first-page":"678","article-title":"Prognostic signs in the surgical management of plexiform neurofibroma: the Children\u2019s Hospital of Philadelphia experience, 1974-1994","volume":"131","author":"Needle","year":"1997","journal-title":"J Pediatr"},{"issue":"3","key":"key\n\t\t\t\t2018111205554742400_CIT0010","first-page":"303","article-title":"Resection of plexiform neurofibromas in children with neurofibromatosis type 1","volume":"31","author":"Canavese","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"key\n\t\t\t\t2018111205554742400_CIT0011","first-page":"643","article-title":"Relationship to age and body weight NF1 plexiform neurofibroma growth rate by volumetric MRI relationship to age and body weight","volume":"68","author":"Dombi","year":"2007","journal-title":"Neurology"},{"issue":"21 Suppl 1","key":"key\n\t\t\t\t2018111205554742400_CIT0012","first-page":"S33","article-title":"Recommendations for imaging tumor response in neurofibromatosis clinical trials","volume":"81","author":"Dombi","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"key\n\t\t\t\t2018111205554742400_CIT0013","first-page":"257","article-title":"Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging","volume":"28","author":"Solomon","year":"2004","journal-title":"Comput Med Imaging Graph"},{"issue":"3","key":"key\n\t\t\t\t2018111205554742400_CIT0014","first-page":"396","article-title":"Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas","volume":"60","author":"Kim","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"key\n\t\t\t\t2018111205554742400_CIT0015","first-page":"707","article-title":"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"16","author":"Widemann","year":"2014","journal-title":"Neuro Oncol"},{"issue":"6","key":"key\n\t\t\t\t2018111205554742400_CIT0016","first-page":"982","article-title":"Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study","volume":"61","author":"Weiss","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"key\n\t\t\t\t2018111205554742400_CIT0017","first-page":"1598","article-title":"Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"61","author":"Widemann","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"key\n\t\t\t\t2018111205554742400_CIT0018","first-page":"1218","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol"},{"issue":"26","key":"key\n\t\t\t\t2018111205554742400_CIT0019","first-page":"2550","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018111205554742400_CIT0020","first-page":"S33","article-title":"Recommendations for imaging tumor response in neurofibromatosis clinical trials","volume":"81","author":"Dombi","year":"2013","journal-title":"Neurology"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/20\/12\/1643\/26495504\/noy067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T05:55:57Z","timestamp":1542002157000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/20\/12\/1643\/4989835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,28]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,4,28]]},"published-print":{"date-parts":[[2018,11,12]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noy067","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,4,28]]}}}